Pilot Trial on the Use of Etanercept and Methylprednisolone as Primary Treatment for Acute Graft-versus-Host Disease

This publication has 29 references indexed in Scilit:

• Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: Comparison of grading systems
  Transplantation and Cellular Therapy, 2002
• A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease
  Transplantation and Cellular Therapy, 2000
• Pathophysiologic mechanisms of acute graft-vs.-host disease
  Transplantation and Cellular Therapy, 1999
• A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment
  Blood, 1991
• A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment
  Blood, 1990
• Graft‐versus‐host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long‐term follow‐up of a controlled trial
  British Journal of Haematology, 1989
• Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial
  Blood, 1989
• Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials
  Blood, 1988
• Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.
  The Journal of Experimental Medicine, 1987
• Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
  New England Journal of Medicine, 1986